Stockreport

Eli Lilly Warns Tirzepatide-B12 Mix in Compounded Drugs May Pose Safety Risks [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF This article first appeared on GuruFocus Eli Lilly ( NYSE:LLY ) has raised new safety concerns around compounded versions of its weight-loss medicine Zepbound, warnin [Read more]